BRTX vs. BNR, OPGN, ENZ, CCM, MRAI, MGRX, KDLY, SSY, OTRK, and ATIP
Should you be buying BioRestorative Therapies stock or one of its competitors? The main competitors of BioRestorative Therapies include Burning Rock Biotech (BNR), OpGen (OPGN), Enzo Biochem (ENZ), Concord Medical Services (CCM), Marpai (MRAI), Mangoceuticals (MGRX), Kindly MD (KDLY), SunLink Health Systems (SSY), Ontrak (OTRK), and ATI Physical Therapy (ATIP). These companies are all part of the "healthcare" industry.
BioRestorative Therapies vs.
Burning Rock Biotech (NASDAQ:BNR) and BioRestorative Therapies (NASDAQ:BRTX) are both small-cap business services companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, community ranking, analyst recommendations, dividends, earnings, risk, valuation and institutional ownership.
Burning Rock Biotech has a beta of 0.67, indicating that its stock price is 33% less volatile than the S&P 500. Comparatively, BioRestorative Therapies has a beta of 68.9, indicating that its stock price is 6,790% more volatile than the S&P 500.
30.0% of Burning Rock Biotech shares are held by institutional investors. Comparatively, 69.4% of BioRestorative Therapies shares are held by institutional investors. 30.3% of Burning Rock Biotech shares are held by insiders. Comparatively, 25.5% of BioRestorative Therapies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Burning Rock Biotech received 3 more outperform votes than BioRestorative Therapies when rated by MarketBeat users. However, 100.00% of users gave BioRestorative Therapies an outperform vote while only 31.25% of users gave Burning Rock Biotech an outperform vote.
In the previous week, BioRestorative Therapies had 7 more articles in the media than Burning Rock Biotech. MarketBeat recorded 7 mentions for BioRestorative Therapies and 0 mentions for Burning Rock Biotech. Burning Rock Biotech's average media sentiment score of 0.00 equaled BioRestorative Therapies'average media sentiment score.
BioRestorative Therapies has a consensus target price of $18.00, suggesting a potential upside of 943.48%. Given BioRestorative Therapies' stronger consensus rating and higher possible upside, analysts clearly believe BioRestorative Therapies is more favorable than Burning Rock Biotech.
Burning Rock Biotech has a net margin of -83.50% compared to BioRestorative Therapies' net margin of -2,697.08%. Burning Rock Biotech's return on equity of -60.68% beat BioRestorative Therapies' return on equity.
BioRestorative Therapies has lower revenue, but higher earnings than Burning Rock Biotech. Burning Rock Biotech is trading at a lower price-to-earnings ratio than BioRestorative Therapies, indicating that it is currently the more affordable of the two stocks.
Summary
BioRestorative Therapies beats Burning Rock Biotech on 11 of the 17 factors compared between the two stocks.
Get BioRestorative Therapies News Delivered to You Automatically
Sign up to receive the latest news and ratings for BRTX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
BioRestorative Therapies Competitors List
Related Companies and Tools
This page (NASDAQ:BRTX) was last updated on 4/4/2025 by MarketBeat.com Staff
Buy BRTX Stock Free BRTX Stock Alerts